These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14530901)

  • 1. Acute effects of memantine in combination with alcohol in moderate drinkers.
    Bisaga A; Evans SM
    Psychopharmacology (Berl); 2004 Feb; 172(1):16-24. PubMed ID: 14530901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers.
    Krishnan-Sarin S; O'Malley SS; Franco N; Cavallo DA; Morean M; Shi J; Pittman B; Krystal JH
    Alcohol Clin Exp Res; 2015 Feb; 39(2):300-7. PubMed ID: 25664775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients.
    Krupitsky EM; Neznanova O; Masalov D; Burakov AM; Didenko T; Romanova T; Tsoy M; Bespalov A; Slavina TY; Grinenko AA; Petrakis IL; Pittman B; Gueorguieva R; Zvartau EE; Krystal JH
    Am J Psychiatry; 2007 Mar; 164(3):519-23. PubMed ID: 17329479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice.
    Escher T; Call SB; Blaha CD; Mittleman G
    Psychopharmacology (Berl); 2006 Sep; 187(4):424-34. PubMed ID: 16835770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute interaction of baclofen in combination with alcohol in heavy social drinkers.
    Evans SM; Bisaga A
    Alcohol Clin Exp Res; 2009 Jan; 33(1):19-30. PubMed ID: 18840257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of memantine during ethanol withdrawal in neonatal rats: effects on long-term ethanol-induced motor incoordination and cerebellar Purkinje cell loss.
    Idrus NM; McGough NN; Riley EP; Thomas JD
    Alcohol Clin Exp Res; 2011 Feb; 35(2):355-64. PubMed ID: 21070252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA antagonists inhibit the development of ethanol dependence in rats.
    Kotlińska J
    Pol J Pharmacol; 2001; 53(1):47-50. PubMed ID: 11785910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for alcohol anti-craving properties of memantine.
    Hölter SM; Danysz W; Spanagel R
    Eur J Pharmacol; 1996 Oct; 314(3):R1-2. PubMed ID: 8957265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol-reinforced behaviour in the rat: effects of uncompetitive NMDA receptor antagonist, memantine.
    Piasecki J; Koros E; Dyr W; Kostowski W; Danysz W; Bienkowski P
    Eur J Pharmacol; 1998 Aug; 354(2-3):135-43. PubMed ID: 9754913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats.
    Sabino V; Narayan AR; Zeric T; Steardo L; Cottone P
    Behav Brain Res; 2013 Jun; 247():9-16. PubMed ID: 23466691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a single memantine treatment on behavioral alterations associated with binge alcohol exposure in neonatal rats.
    Idrus NM; McGough NN; Spinetta MJ; Thomas JD; Riley EP
    Neurotoxicol Teratol; 2011; 33(4):444-50. PubMed ID: 21565269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine enhances the inhibitory effects of naltrexone on ethanol consumption.
    Kuzmin A; Stenback T; Liljequist S
    Eur J Pharmacol; 2008 Apr; 584(2-3):352-6. PubMed ID: 18339371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor impairment produced by ethanol and site-selective NMDA receptor antagonists in mice: tolerance and cross-tolerance.
    Neznanova ON; Blokhina EA; Sukhotina IA; Bespalov AY
    Alcohol; 2000 Jan; 20(1):31-6. PubMed ID: 10680714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers.
    Comer SD; Sullivan MA
    Psychopharmacology (Berl); 2007 Aug; 193(2):235-45. PubMed ID: 17406858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
    Kozela E; Pilc A; Popik P
    Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol discrimination in the rat: lack of modulation by restraint stress and memantine.
    Koros E; Kostowski W; Danysz W; Bienkowski P
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Feb; 359(2):117-22. PubMed ID: 10048596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.
    Bisaga A; Comer SD; Ward AS; Popik P; Kleber HD; Fischman MW
    Psychopharmacology (Berl); 2001 Aug; 157(1):1-10. PubMed ID: 11512037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.
    Farlow MR
    Geriatrics; 2004 Jun; 59(6):22-7. PubMed ID: 15224791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of memantine.
    Johnson JW; Kotermanski SE
    Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.